Literature DB >> 26077424

DNA methylation, insulin resistance and second-generation antipsychotics in bipolar disorder.

Kyle J Burghardt1, Jacyln M Goodrich2, Dana C Dolinoy2, Vicki L Ellingrod3,4.   

Abstract

AIMS: This study aimed to assess the effect of second-generation antipsychotic (SGA) use and insulin resistance on a global measure of DNA methylation in patients diagnosed with bipolar disorder. MATERIALS &
METHODS: Subjects stable on medication (either mood stabilizer monotherapy or adjuvant SGAs) were assessed for insulin resistance. Global methylation levels were assessed in leukocyte DNA from whole blood using the Luminometric Methylation Assay. Multivariable linear regression was used to investigate the effect of insulin resistance and SGA use on DNA methylation.
RESULTS: A total of 115 bipolar I subjects were included in this study. The average age was 43.1 ±12.2 years and 73% were on SGAs. Average% global methylation was 77.0 ± 3.26 and was significantly influenced by insulin resistance, SGA use and smoking.
CONCLUSION: This is the first study to show a relationship between SGA use, insulin resistance and global DNA methylation. Further work will be needed to identify tissue- and gene-specific methylation changes.

Entities:  

Keywords:  antipsychotic; bipolar; global DNA methylation; insulin resistance

Mesh：

Substances：

Year:  2015        PMID： 26077424      PMCID： PMC4501018          DOI： 10.2217/epi.15.5

Source DB:  PubMed          Journal:  Epigenomics        ISSN： 1750-192X            Impact factor:   4.778


  49 in total

1.  Variation, patterns, and temporal stability of DNA methylation: considerations for epigenetic epidemiology.

Authors:  Rudolf P Talens; Dorret I Boomsma; Elmar W Tobi; Dennis Kremer; J Wouter Jukema; Gonneke Willemsen; Hein Putter; P Eline Slagboom; Bastiaan T Heijmans
Journal:  FASEB J       Date:  2010-04-12       Impact factor: 5.191

2.  Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state.

Authors:  S M Haffner; L Mykkänen; A Festa; J P Burke; M P Stern
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

3.  Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset.

Authors:  Philippe A Melas; Maria Rogdaki; Urban Ösby; Martin Schalling; Catharina Lavebratt; Tomas J Ekström
Journal:  FASEB J       Date:  2012-03-16       Impact factor: 5.191

4.  Association between inflammation and insulin resistance in U.S. nondiabetic adults: results from the Third National Health and Nutrition Examination Survey.

Authors:  Jing Chen; Rachel P Wildman; L Lee Hamm; Paul Muntner; Kristi Reynolds; Paul K Whelton; Jiang He
Journal:  Diabetes Care       Date:  2004-12       Impact factor: 19.112

Review 5.  DNA methylation in obesity and type 2 diabetes.

Authors:  Vanessa Derenji Ferreira de Mello; Leena Pulkkinen; Marianne Lalli; Marjukka Kolehmainen; Jussi Pihlajamäki; Matti Uusitupa
Journal:  Ann Med       Date:  2014-04-30       Impact factor: 4.709

6.  Mercury-associated DNA hypomethylation in polar bear brains via the LUminometric Methylation Assay: a sensitive method to study epigenetics in wildlife.

Authors:  J Richard Pilsner; Alicia L Lazarus; Dong-Ha Nam; Robert J Letcher; Christian Sonne; Rune Dietz; Niladri Basu
Journal:  Mol Ecol       Date:  2009-12-03       Impact factor: 6.185

7.  Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants.

Authors:  Vicki L Ellingrod; Del D Miller; Stephan F Taylor; Jessica Moline; Timothy Holman; Jane Kerr
Journal:  Schizophr Res       Date:  2007-10-31       Impact factor: 4.939

8.  Methylenetetrahydrofolate reductase (MTHFR) 677C/T polymorphism is associated with antipsychotic-induced weight gain in first-episode schizophrenia.

Authors:  Umarat Srisawat; Gavin P Reynolds; Zhi Jun Zhang; Xiang Rong Zhang; Belen Arranz; Luis San; Caroline F Dalton
Journal:  Int J Neuropsychopharmacol       Date:  2013-11-13       Impact factor: 5.176

Review 9.  Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles.

Authors:  H A Nasrallah
Journal:  Mol Psychiatry       Date:  2007-09-11       Impact factor: 15.992

10.  Global LINE-1 DNA methylation is associated with blood glycaemic and lipid profiles.

Authors:  Mark S Pearce; James C McConnell; Catherine Potter; Laura M Barrett; Louise Parker; John C Mathers; Caroline L Relton
Journal:  Int J Epidemiol       Date:  2012-02       Impact factor: 7.196
View more
  15 in total

1.  Sex Differences in Antipsychotic Related Metabolic Functioning in Schizophrenia Spectrum Disorders.

Authors:  A Zarina Kraal; Kristen M Ward; Vicki L Ellingrod
Journal:  Psychopharmacol Bull       Date:  2017-05-15

Review 2.  The role of DNA methylation in the pathophysiology and treatment of bipolar disorder.

Authors:  Gabriel R Fries; Qiongzhen Li; Blake McAlpin; Theo Rein; Consuelo Walss-Bass; Jair C Soares; Joao Quevedo
Journal:  Neurosci Biobehav Rev       Date:  2016-06-18       Impact factor: 8.989

3.  Skeletal muscle DNA methylation modifications and psychopharmacologic treatment in bipolar disorder.

Authors:  Kyle J Burghardt; Bradley H Howlett; Elani Sanders; Sabrina E Dass; Zaher Msallaty; Abduallah Mallisho; Berhane Seyoum; Zhengping Yi
Journal:  Eur Neuropsychopharmacol       Date:  2019-10-19       Impact factor: 4.600

4.  Antipsychotic Medications and DNA Methylation in Schizophrenia and Bipolar Disorder: A Systematic Review.

Authors:  Kyle J Burghardt; Audrey S Khoury; Zaher Msallaty; Zhengping Yi; Berhane Seyoum
Journal:  Pharmacotherapy       Date:  2020-03-09       Impact factor: 4.705

5.  Oxytocin Receptor (OXTR) Methylation and Cognition in Psychotic Disorders.

Authors:  Tyler B Grove; Kyle J Burghardt; A Zarina Kraal; Ryan J Dougherty; Stephan F Taylor; Vicki L Ellingrod
Journal:  Mol Neuropsychiatry       Date:  2016-08-13

6.  Gene-specific DNA methylation may mediate atypical antipsychotic-induced insulin resistance.

Authors:  Kyle J Burghardt; Jacyln M Goodrich; Dana C Dolinoy; Vicki L Ellingrod
Journal:  Bipolar Disord       Date:  2016-08-20       Impact factor: 6.744

Review 7.  Cardiometabolic effects of psychotropic medications.

Authors:  Oluchi Abosi; Sneha Lopes; Samantha Schmitz; Jess G Fiedorowicz
Journal:  Horm Mol Biol Clin Investig       Date:  2018-01-10

8.  The epigenetic signature of systemic insulin resistance in obese women.

Authors:  Peter Arner; Anna-Stina Sahlqvist; Indranil Sinha; Huan Xu; Xiang Yao; Dawn Waterworth; Deepak Rajpal; A Katrina Loomis; Johannes M Freudenberg; Toby Johnson; Anders Thorell; Erik Näslund; Mikael Ryden; Ingrid Dahlman
Journal:  Diabetologia       Date:  2016-08-18       Impact factor: 10.122

Review 9.  Epigenetics of Hepatic Insulin Resistance.

Authors:  Hannah Maude; Claudia Sanchez-Cabanillas; Inês Cebola
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-11       Impact factor: 5.555

10.  Genetic Variation in One-Carbon Metabolism and Changes in Metabolic Parameters in First-Episode Schizophrenia Patients.

Authors:  Blazej Misiak; Lukasz Laczmanski; Natalia Kinga Sloka; Elzbieta Szmida; Ryszard Slezak; Patryk Piotrowski; Andrzej Kiejna; Dorota Frydecka
Journal:  Int J Neuropsychopharmacol       Date:  2017-03-01       Impact factor: 5.176
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.